Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:GILD
Tag: NASDAQ:GILD
Gilead Sciences, Inc. (NASDAQ:GILD) HCV Portfolio Strengthened With Vosevi Approval
Andy Parker
-
July 20, 2017
0
Hepatitis C Treatment From Gilead Sciences, Inc. (NASDAQ:GILD) Approved By FDA
-
July 19, 2017
0
Gilead Sciences, Inc. (NASDAQ:GILD), Sanofi SA (ADR) (NYSE:SNY) Eyeing TESARO Inc...
-
June 13, 2017
0
CFO of Gilead Sciences, Inc. (NASDAQ:GILD) Named 2017 Financial Woman of...
Andy Parker
-
May 30, 2017
0
GILEAD SCIENCES, INC. (NASDAQ:GILD) Files An 8-K Submission of Matters to...
ME Staff 8-k
-
May 18, 2017
0
GILEAD SCIENCES,INC. (NASDAQ:GILD) Files An 8-K Departure of Directors or Certain...
ME Staff 8-k
-
May 12, 2017
0
GILEAD SCIENCES, INC. (NASDAQ:GILD) Files An 8-K Results of Operations and...
ME Staff 8-k
-
May 2, 2017
0
Bristol-Myers Squibb Co (NYSE:BMY) NASH Drug Next Big Thing on Liver...
-
April 24, 2017
0
Humanitarian Organizations Challenge Gilead Sciences, Inc. (NASDAQ:GILD) Sovaldi Patent
-
March 28, 2017
0
Merck & Co., Inc. (NYSE:MRK) In $2.9 Billion Writedown After Market...
Andy Parker
-
February 24, 2017
0
1
...
3
4
5
...
7
Page 4 of 7
